Download PDF
Thromb Haemost 1996; 75(04): 698-699
DOI: 10.1055/s-0038-1650349
Letter to the Editor
Schattauer GmbH Stuttgart

The Discrimination of Factor XII Deficiency and Lupus Anticoagulant

Walter-Michael Halbmayer
The Central Laboratory and Thrombophilia-Center of the Municipal Hospital Vienna-Lainz, Austria
,
Alexander Haushofer
The Central Laboratory and Thrombophilia-Center of the Municipal Hospital Vienna-Lainz, Austria
,
Veronika Angerer
The Central Laboratory and Thrombophilia-Center of the Municipal Hospital Vienna-Lainz, Austria
,
Michael Fischer
The Central Laboratory and Thrombophilia-Center of the Municipal Hospital Vienna-Lainz, Austria
› Author Affiliations
Further Information

Publication History

Received 11 October 1995

Accepted after revision 18 December 1995

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Martinez-Saguer I, Becker S, Lenz E, Escuriola-Ettinghausen C, Scharrer I, Dingeldein E, Kreuz W. Various APTT and F XH-assays in a family with heterozygous F XH-deficiency. Ann Hematol 1995; 70 (Suppl. 01) A 65 (abstract)
    CrossrefPubMedGoogle Scholar
  • 2 Brookfield C, Malia RG, Cooper SM, Greaves M. Factor XII levels and the lupus anticoagulant. Thromb Haemost 1995; 73: 1276 (abstract)
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Sklavou S, Digenopoulou E, Spiliotopoulou I, Kontopoulou I. The prevalence of F XII deficiency among patients suffering from venous or arterial thromboembolism of unknown origin and among those with lupus anticoagulants. Thromb Haemost 1995; 73: 1407 (abstract)
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Halbmayer W-M, Haushofer A, Schön R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M. The prevalence of moderate and severe F XII (Hageman factor) deficiency among the normal population: Evaluation of the Incidence of F XII deficiency among 300 healthy blood donors. Thromb Haemost 1994; 71: 68-72
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 von Känel R, Wuillemin WA, Furlan M, Lämmle B. Factor XII clotting activity and antigen levels in patients with thrombotic disease. Blood Coag Fibrinolysis 1992; 3: 555-561
    CrossrefPubMedGoogle Scholar
  • 6 Koster T, Rosendaal FR, Briët E, Vandenbroucke JP. John Hageman’s factor and deep-vein thrombosis: Leiden thrombophilia study. British J Haematol 1994; 87: 422-424
    CrossrefPubMedGoogle Scholar
  • 7 Halbmayer W-M, Haushofer A, Radek J, Schon R, Deutsch M, Fischer M. Prevalence of F XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery. Coronary Artery Disease 1994; 5: 451-454
    CrossrefPubMedGoogle Scholar
  • 8 Halbmayer W-M, Mannhalter C, Fischer M. Faktor-XII-Mangel und Thrombophilie. Hamostaseologie 1993; 13: 157-160
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Galli M, Finazzi G, Bevers EM, Barbui T. Kaolin clotting time and dilute Russel’s viper venom time distinguish between prothrombin-dependent and β2-glycoprotein I-dependent antiphospholipid-antibodies. Blood 1995; 86: 617-623
    PubMedGoogle Scholar
  • 10 Gallimore MJ, Rees WA, Fuhrer G, Heller W. A direct chromogenic peptide substrate assay for Hageman factor (F XII). Fibrinolysis 1987; 1: 123-127
    PubMedGoogle Scholar
  • 11 Green D, Hougie C, Kazmier FJ, Lechner K, Mannucci PM, Rizza CR, Sultan Y. Report of the working party on acquired inhibitors of coagulation: Studies of the „lupus‟ anticoagulant. Thromb Haemost 1983; 49: 144-146
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on lupus anticoagulant/antiphospholipid antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-1190
    Article in Thieme ConnectPubMedGoogle Scholar